RT Conference Proceedings
T1 Predictors of 18F-fluorodeoxyglucose (F) positron-emission tomography (PET)-driven disease detection in patients (pts) with HER2[+] early breast cancer (EBC). A substudy of the PHERGain trial
A1 Llombart Cussac, A.
A1 Prat, A.
A1 Perez-Garcia, J. M.
A1 Mateos, J.
A1 Pascual, T.
A1 Escriva-De-Romani, S.
A1 Stradella, A.
A1 Ruiz-Borrego, M.
A1 Bermejo De Las Heras, B.
A1 Keyaerts, M.
A1 Sampayo-Cordero, M.
A1 Malfettone, A.
A1 Cortes, R.
A1 Galvan, P.
A1 Cortes, J.
A1 Gebhart, G.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-05-01
LK https://hdl.handle.net/10668/27210
UL https://hdl.handle.net/10668/27210
LA en
DS RISalud
RD Apr 7, 2025